Stephen Tsang, Columbia University - Keynote Speaker at Ocular Disease Conference
|
Stephen Tsang, Associate Director, Edward S. Harkness Eye Institute, Columbia University/New York Presbyterian Hospital will give a Keynote Presentation on Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in a Mouse Model for Retinitis Pigmentosa at GTCbio’s 2nd Annual Ocular Disease Drug & Discovery Conference on May 27 ' 28, 2010 in Boston, MA.
Stephen Tsang will present his recent studies on retinal pigment epithelium. The highlight of his presentation will include how differentiated ES cells could become a new therapeutic approach for diseases such as age-related macular degeneration, and certain forms of retinitis pigmentosa featuring loss of retinal pigmented epithelial cells.
GTCbio’s Ocular Disease conference will also bring together leading academics from Harvard, Columbia University, National Eye Institute as well as Industries from Pfizer, GlaxoSmithKline, and Genzyme. Updates on the age related macular degeneration, recent drug developments & mechanisms, ocular disease, and future of ocular disease therapeutics will be addressed and discussed.
GTCbio’s 2nd Annual conference on Ocular Disease Drug and Discovery will provide cutting edge information and a chance to exchange ideas from leading experts in the field. Don’t miss this opportunity to register for GTCbio’s 2nd Annual Ocular Disease Drug and Discovery conference. Please check our web for the most up to date information: http://www.gtcbio.com/ conferenceDetails.aspx?id=148
User comments, Ratings and Reviews
Read more!
[Bookmark & read later
/ Comment this story ]
GTCbio from 59.95.187.xxx
Article Taged as : stephen, tsang,, columbia, university, keynote, speaker, ocular, disease, conference, http, www.gtcbio.com, stephen, tsang,, columbia, university, keynote, speaker, ocular, disease, conference,
|
Article Statistics
Article Viewed 2170 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]
News Article Source & Groups
You can find this article under group.
And brought to you by Channel ,
The XMl Feed Type and collected data bytes sized news and still counting.
Feed Server name is and Code Page (Not Defined/Un Known)
: : Stephen Tsang, Columbia University - Keynote Speaker at Ocular Disease Conference
Date Listed : Thursday, March 18, 2010
Source : ,
|
Related Stories
- New Online Conference Analyzes Top Cloud Computing Trends and Challenges
TORONTO--(BUSINESS WIRE)--Cloud Slam ’09, a virtual conference developed to promote collaborative analysis of the latest trends and challenges in the world of cloud computing. Organized by more than 30 leading ...- Innovations in technology and the modern luxury hotel Columbia
Technology has left its impact in every walk of life, how can the luxuries in the hotels be untouched of it. Today, if we compare our stay at any hotel ...- Stephen Tsang, Columbia University - Keynote Speaker at Ocular Disease Conference
Stephen Tsang, Associate Director, Edward S. Harkness Eye Institute, Columbia University/New York Presbyterian Hospital will give a Keynote Presentation on Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in ...- Targets Of Deception A New Book From Author Jeffrey Stephens
Greenwich, CT, March 17, 2010 - Targets of Deception ( Variance Publishing ), while written as fiction, is based on actual events and Stephens’ hair-raising tale of espionage has readers ...- Business & Industry Leaders to Convene at 2nd Annual CloudSlam’10™ Conference
Toronto (PRWEB) March 8, 2010 -- CloudSlam’10™, a virtual conference produced by Cloudcor Inc™ & developed to promote collaborative analysis of the latest trends and challenges in the world of ...- Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
The global Huntington’s disease (HD) market was worth $243m in 2009. The market is expected to grow by 17.4% during the next seven years to reach $748m by 2016. Earlier, ...- Rudolf Jaenisch, Ph. D., to give Keynote Presentation at Annual Stem Cell Conference
Rudolf Jaenisch, Ph.D, Founding Member of The Whitehead Institute and Professor of Biology at the Massachusetts Institute of Technology will give the Keynote address entitled “Commercialization of Regenerative Medicine: ES cells, ...- Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
The coronary artery disease (CAD) market is a highly competitive market and is expected to become more competitive until 2016. Three major patent expiries are expected during the forecast period, ...- "Time to turn off the TV and Radio," claims Motivational Speaker
Internationally Acclaimed Motivational Speaker has called on the media to move away from their position of "prophets of doom and gloom" towards becoming a medium that highlights “pictures of possibility.”
"In ...- "Time to turn off the TV and Radio,"claims Motivational Speaker
Internationally Acclaimed Motivational Speaker has called on the media to move away from their position of “prophets of doom and gloom” towards becoming a medium that highlights “pictures of possibility.”
“In ...
|
|
|
